Page last updated: 2024-09-04

25-hydroxyprotopanaxadiol and Invasiveness, Neoplasm

25-hydroxyprotopanaxadiol has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, X; Fan, D; Hou, Y; Jiang, B; Liu, Y; Mou, T; Wang, P; Xia, X; Zhao, Y1

Other Studies

1 other study(ies) available for 25-hydroxyprotopanaxadiol and Invasiveness, Neoplasm

ArticleYear
Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition.
    European journal of pharmacology, 2014, Nov-05, Volume: 742

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Ginsenosides; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Panax; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2014